The effect of a pharmacist consultation on pregnant women's quality of life with a special focus on nausea and vomiting: an intervention study

• Published in: BMC pregnancy and childbirth 2020-12, Vol.20 (1), p.766-766, Article 766
• Main Authors: Truong, Maria Bich-Thuy, Ngo, Elin, Ariansen, Hilde, Tsuyuki, Ross T, Nordeng, Hedvig
• Format: Article
• Language: English
• Subjects: Adult; Case-Control Studies; Community pharmacy; Drug stores; Enrollments; Feasibility studies; Female; Humans; Intervention; Medications; Nausea - drug therapy; Nausea - psychology; Nausea and vomiting in pregnancy; Norway; Obstetrics; Patient Satisfaction; Pharmacist intervention; Pharmacists; Pregnancy; Pregnancy Complications - drug therapy; Pregnancy Complications - psychology; Pregnancy Trimester, First; Prenatal care; Quality of Life; Referral and Consultation - standards; Severity of Illness Index; Surveys and Questionnaires; Vomiting - drug therapy; Vomiting - psychology; Womens health
• ISSN: 1471-2393; 1471-2393
• DOI: 10.1186/s12884-020-03472-z

Maternal wellbeing and quality of life (QOL) are increasingly being recognized as important for healthy pregnancies. The aim of this study was to investigate the impact of a pharmacist consultation on pregnant women's QOL focusing on nausea and vomiting in pregnancy (NVP), and patient satisfaction. For this intervention study in 14 community pharmacies, women in early pregnancy were recruited and assigned to a pharmacist consultation (intervention) or standard care (control). The consultation aimed to address each woman's concerns regarding medications and pregnancy-related ailments. Data were collected through online questionnaires at baseline (Q1) and during the second trimester (Q2). The intervention group completed an additional satisfaction questionnaire after the consultation was completed. The primary outcome was the impact of the intervention on the Quality of Life Scale (QOLS) scores between the first and second trimesters. The impact of the intervention was assessed by linear regression, and secondary analyses were performed to assess effect modification by NVP. Of the 340 women enrolled in the study, we analyzed data for 245. Half (170/340) of the original participants were allocated to the intervention group, of whom 131 received the pharmacist consultation. Most women (75%, 78/96) reported that the consultation was useful to a large/very large extent. The consultation had no overall impact on QOLS scores between the first and the second trimesters compared with standard care (adjusted β: 0.7, 95% CI: -2.1, 3.4). The impact of the intervention on QOLS was greater amongst women with moderate/severe NVP (adjusted β: 3.6, 95% CI: -0.6, 7.7) compared to those with no/mild NVP (adjusted β: -1.4, 95% CI: -5.1, 2.2) (interaction term study group*NVP severity, p = 0.048). The pregnant women highly appreciated the pharmacist consultation, but the intervention did not affect their QOL scores compared with standard care. Future studies should further explore the effect of a pharmacist consultation specifically for NVP and on other outcomes such as use of health care services and medication use in pregnancy. Retrospectively registered in ClinicalTrials.gov (identifier: NCT04182750 , registration date: December 2, 2019).